COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 54 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Prophylaxis.
Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 169 | 17.8% | 85 | 50 |
| Haemorrhage | 129 | 13.6% | 21 | 53 |
| Drug ineffective | 117 | 12.3% | 26 | 47 |
| Death | 85 | 8.9% | 85 | 8 |
| Pre-existing disease | 78 | 8.2% | 78 | 22 |
| Therapy partial responder | 78 | 8.2% | 76 | 23 |
| Acquired haemophilia | 72 | 7.6% | 70 | 23 |
| Haemarthrosis | 47 | 4.9% | 3 | 27 |
| Haematoma | 30 | 3.2% | 3 | 21 |
| Therapy responder | 30 | 3.2% | 27 | 22 |
| Thrombosis | 27 | 2.8% | 6 | 12 |
| Condition aggravated | 23 | 2.4% | 8 | 11 |
| Shock haemorrhagic | 20 | 2.1% | 14 | 8 |
| Epistaxis | 19 | 2.0% | 0 | 13 |
| Haemorrhage intracranial | 19 | 2.0% | 7 | 8 |
Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Acquired haemophilia (244)
Factor viii deficiency (130)
Product used for unknown indication (97)
Haemorrhage (92)
Factor vii deficiency (51)
Haemophilia (44)
Haemophilia a with anti factor viii (43)
Factor ix deficiency (36)
Haemostasis (30)
Off label use (26)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)